Physician profile

Marcelo Branco

Clinical Cardiac Electrophysiology · Pensacola, FL

NPI 1972592715

$10,295.49

in general payments reported to CMS, 2019-2025

40 companies · $1,381 in 2025

The $1,381 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,153.95
Travel and Lodging$1,536.91

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $4,217.48 2020-2025 Aveir, Amplatzer Amulet, Jot Dx
Biosense Webster, INC. $898.58 2021-2025 Carto 3, Qdot Micro Catheter
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $825.38 2019-2025 Lifevest
Novartis Pharmaceuticals Corporation $392.86 2019-2022
Janssen Pharmaceuticals, INC $389.58 2019-2023 Xarelto
Boston Scientific Corporation $344.03 2022-2025 Watchman Flx, Watchman, Watchman Access System
E.R. Squibb & Sons, L.L.C. $335.28 2019-2024 Eliquis, Camzyos
Philips North America LLC $285.06 2019-2023 (9520) Igt Devices Undivided
Amgen INC. $247.77 2019-2025 Repatha, Repatha
Medtronic, INC. $196.76 2024-2025 Affera Mapping System, Cobalt Dr Mri Surescan
Medtronic Vascular, INC. $186.07 2019-2020
Astellas Pharma US INC $180.24 2019-2020
Pfizer INC. $179.76 2019-2025
Kestra Medical Technology Services, INC. $165.98 2024-2025 Assure Wcd
Cvrx, INC. $149.64 2023-2024 Barostim Neo System
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals Lp $130.55 2019-2023 Farxiga
Sanofi-Aventis U.S. LLC $122.18 2019-2022
Braemar Manufacturing, LLC $119.66 2019
Boehringer Ingelheim Pharmaceuticals, INC. $109.25 2019-2020
Cardiva Medical, INC. $96.11 2019-2024 Cardiva Vascade Mvp Vvcs 6-12f
Acutus Medical, INC. $88.71 2022
Actelion Pharmaceuticals US, INC. $87.73 2019-2022
Baxter Healthcare $76.72 2024 Hillrom - Carnation Ambulatory Monitor
Cook Medical LLC $56.62 2024 Evolution
Abiomed $51.03 2019
Portola Pharmaceuticals, LLC $38.45 2019-2020
Gilead Sciences, INC. $35.62 2019
Osprey Medical INC $34.00 2019
Merck Sharp & Dohme LLC $33.50 2021-2022
Amarin Pharma, INC. $30.71 2019
Irhythm Technologies, INC. $29.93 2023 Zio Xt Patch
Celonova Biosciences, INC. $24.38 2019-2020
Lundbeck LLC $22.78 2019
Csl Behring $18.95 2019
United Therapeutics Corporation $18.15 2020
Impulse Dynamics (USA) INC. $17.58 2023 Optimizer
Atricure, INC. $16.07 2019
Elutia, INC. $15.66 2023
Regeneron Healthcare Solutions, INC. $13.43 2019
Cardiovascular Systems INC. $13.25 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Marcelo Branco

$10,295.49

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $1,381 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).

https://glasscript.com/doctor/134528/marcelo-branco

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.